Free Trial
→ Why Iran May Only Be the First Move (From Behind the Markets) (Ad)tc pixel
OTCMKTS:SUSRF

Surgical Science Sweden AB (publ) Earnings Date & Estimates

Surgical Science Sweden AB (publ) logo
$5.48 0.00 (0.00%)
As of 11/6/2026

Surgical Science Sweden AB (publ) is estimated to report earnings on Thursday, November 12, 2026.

Research:ProfileForecast

Upcoming Earnings Announcement

Announcement Date
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ) is expected to post earnings of $0.0681 per share on revenue of $26.06 million.

Consensus Estimates

Consensus EPS
$0.0681
Expected Revenue
$26.06 million

Prepare for the Earnings Call

Surgical Science Sweden AB (publ) Earnings FAQ

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) is estimated to report earnings on Thursday, November 12, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Surgical Science Sweden AB (publ) to post earnings of $0.0681 per share for the quarter.

The consensus revenue estimate for Surgical Science Sweden AB (publ) is $26.06 million for the quarter.

Surgical Science Sweden AB (publ) Earnings Headlines

Surgical Science Sweden AB (publ) (SUSRF) Projected to Announce Quarterly Earnings on Thursday
November 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31179428
Surgical Science Sweden AB (publ) (SUSRF) Q1 2026 Earnings Call Transcript
May 20, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4907218-surgical-science-sweden-ab-publ-susrf-q1-2026-earnings-call-transcript
The warning signs most investors see too late
Dr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. Now, after 55 years of market analysis, he says conditions are forming for a financial crisis that could rival or exceed 2008.tc pixel
November 10 at 1:00 AM  |  Weiss Ratings (Ad)
Surgical Science Sweden AB (publ) (SUSRF) Analyst/Investor Day Transcript
December 8, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4851213-surgical-science-sweden-ab-publ-susrf-analyst-investor-day-transcript
See More Surgical Science Sweden AB (publ) Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Surgical Science Sweden AB (publ)? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surgical Science Sweden AB (publ) and other key companies, straight to your email.

About Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) develops simulation-based training and assessment solutions for medical professionals. Its products use virtual reality and other simulation technologies to help users practise surgical techniques in a controlled environment.

The company’s offerings cover areas including laparoscopic, endoscopic and robotic surgery, as well as other clinical skills. Surgical Science serves hospitals, universities and medical-device companies, and works with industry partners to incorporate simulation and training tools into their products and education programs.

Founded in Sweden in 1999, the company serves customers internationally. It expanded its simulation portfolio through its 2021 acquisition of Simbionix, a medical simulation business previously owned by 3D Systems.

View Surgical Science Sweden AB (publ) Profile
Earnings Tools